Calyx Completes Private Placement

Calyx Completes Private Placement

ID: 503757

(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/31/16 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to announce that it has completed a non-brokered private placement of 5,715,856 units (each, a "Unit"), at a price of $0.07 per Unit, for gross proceeds of $400,110. Each Unit consists one common share of the Company, and one-half-of-one common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant is exercisable to acquire one additional common share of the Company at a price of $0.15 per share for a period of twenty-four months.

All securities issued in connection with the private placement are subject to a four-month-and-one-day statutory hold period expiring on March 1, 2017.

The Company is also pleased to announce that as a result of the exercise of 2,400,000 incentive stock options, the Company has raised a further $120,000. Proceeds from the private placement and the exercise of stock options will be utilized by the Company to support operations and ongoing business development.

About Calyx

Calyx's wholly-owned subsidiary, Cannigistics Agri-Solutions Corp, is a software development company that has created a software platform tailored to advanced indoor agriculture. The Cannigistics software platform is designed to enhance the efficiency and effectiveness of indoor agricultural operations, and positions Cannigistics to be the industry leader in agri-software solutions by providing businesses with advanced controls over all aspects of their operations. Additionally, Calyx owns a portfolio of proprietary intellectual property with applications in crop enhancement.

For further information about Calyx, please visit .

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:




Roger Forde
President and Chief Executive Officer
Calyx Bio-Ventures Inc.
604.880.8822

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Theratechnologies: Results of HIV Biologic and Long-Acting Investigational Antiretroviral Ibalizumab to be Presented in Late-Breaker Session at IDWeek 2016(TM) ANGLE plc: Notice of GM
Bereitgestellt von Benutzer: Marketwired
Datum: 31.10.2016 - 12:00 Uhr
Sprache: Deutsch
News-ID 503757
Anzahl Zeichen: 0

contact information:
Town:

VANCOUVER, BRITISH COLUMBIA



Kategorie:

Biotech



Diese Pressemitteilung wurde bisher 213 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Calyx Completes Private Placement"
steht unter der journalistisch-redaktionellen Verantwortung von

Calyx Bio-Ventures Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Calyx to Acquire Software Assets and Clients ...

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/13/17 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to announce that it has entered into a letter agreement to acquire the remaining softwa ...

CORRECTION FROM SOURCE: Calyx Provides Corporate Update ...

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/17 -- This document corrects and replaces the press release that was sent today at 8:00 am ET. The embedded URL was changed.Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the &q ...

Calyx Provides Corporate Update ...

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/17 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to provide an update on its ongoing business operations and the development of its indu ...

Alle Meldungen von Calyx Bio-Ventures Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z